Home » Dea Capital: board evaluates the appropriate offer price, Equita to support the directors in the evaluation

Dea Capital: board evaluates the appropriate offer price, Equita to support the directors in the evaluation

by admin
Dea Capital: board evaluates the appropriate offer price, Equita to support the directors in the evaluation

The Board of Directors of Dea Capital deemed the consideration of

1.50 euro “cum dividend” per share envisaged as part of the voluntary public purchase offer for all Dea Capital shares.

The offer, promoted by the offeror Nova, a company wholly owned by De Agostini, was launched on a number of shares equal to approximately 32% of the share capital of Dea Capital, for a total maximum outlay of 129 million euro.

Equita supported the independent directors of Dea Capital in evaluating the consideration for the takeover bid and issued a fairness opinion on the adequacy of the same from a financial point of view.

See also  Resolution 12 of 02/20/2024 - Stipulation of insurance policies Ecc.ma Camera - Zurich Insurance Europe AG period from 31 March 2024 to 31 March 2025 and authorization of expenditure

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy